Take Your Trading To The Next Level. Get Started Here!

Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

July 4, 2024 Comments Off

Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.